These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12032161)

  • 1. Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice.
    Kako Y; Massé M; Huang LS; Tall AR; Goldberg IJ
    J Lipid Res; 2002 Jun; 43(6):872-7. PubMed ID: 12032161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
    Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.
    Le Goff W; Guerin M; Chapman MJ
    Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis.
    Kako Y; Huang LS; Yang J; Katopodis T; Ramakrishnan R; Goldberg IJ
    J Lipid Res; 1999 Dec; 40(12):2185-94. PubMed ID: 10588944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein.
    Marotti KR; Castle CK; Boyle TP; Lin AH; Murray RW; Melchior GW
    Nature; 1993 Jul; 364(6432):73-5. PubMed ID: 8316302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholesterol ester transfer protein (CETP)].
    Nakaya N
    Nihon Rinsho; 1994 Dec; 52(12):3164-9. PubMed ID: 7853706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans.
    Grass DS; Saini U; Felkner RH; Wallace RE; Lago WJ; Young SG; Swanson ME
    J Lipid Res; 1995 May; 36(5):1082-91. PubMed ID: 7658156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
    Yagyu H; Lutz EP; Kako Y; Marks S; Hu Y; Choi SY; Bensadoun A; Goldberg IJ
    J Biol Chem; 2002 Mar; 277(12):10037-43. PubMed ID: 11790777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice.
    Casquero AC; Berti JA; Salerno AG; Bighetti EJ; Cazita PM; Ketelhuth DF; Gidlund M; Oliveira HC
    J Lipid Res; 2006 Jul; 47(7):1526-34. PubMed ID: 16603720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins.
    Tall AR; Sammett D; Vita GM; Deckelbaum R; Olivecrona T
    J Biol Chem; 1984 Aug; 259(15):9587-94. PubMed ID: 6746661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis.
    Sammett D; Tall AR
    J Biol Chem; 1985 Jun; 260(11):6687-97. PubMed ID: 3838987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice.
    Berti JA; Salerno AG; Bighetti EJ; Casquero AC; Boschero AC; Oliveira HC
    APMIS; 2005 Jan; 113(1):37-44. PubMed ID: 15676013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins.
    Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; van Tol A
    J Lipid Res; 2004 May; 45(5):805-11. PubMed ID: 14993244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles.
    Jiang XC; Masucci-Magoulas L; Mar J; Lin M; Walsh A; Breslow JL; Tall A
    J Biol Chem; 1993 Dec; 268(36):27406-12. PubMed ID: 8262982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
    Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptozotocin-induced increase in cholesterol ester transfer protein (CETP) and its reversal by insulin in transgenic mice expressing human CETP.
    Cheema SK; Rashid-Kolvear F
    Can J Physiol Pharmacol; 2003 Oct; 81(10):997-1004. PubMed ID: 14608418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.
    Riemens SC; Van Tol A; Stulp BK; Dullaart RP
    J Lipid Res; 1999 Aug; 40(8):1467-74. PubMed ID: 10428983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.